Loading company…
MoleculeMind develops AI tools for protein design and optimization.
MoleculeMind develops MoleculeOS, a deep-learning platform for designing and optimizing proteins, peptides, antibodies, and enzymes. Its technology is intended for applications in life sciences, chemistry, materials, synthetic biology, agriculture, and industry. Founded in 2022 and based in Beijing, China, the company established labs with research institutions and collaborated with Merck and Roche on AI drug research. It closed a series A round in June 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in